[{"address1": "Fitzwilliam Court", "address2": "1st Floor Leeson Close", "city": "Dublin", "zip": "D02 YW24", "country": "Ireland", "phone": "353 1 669 4820", "website": "https://www.iterumtx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and intravenous formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.", "fullTimeEmployees": 14, "companyOfficers": [{"maxAge": 1, "name": "Mr. Corey N. Fishman", "age": 58, "title": "President, CEO & Director", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 1298811, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Judith M. Matthews", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 747774, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael W. Dunne M.D.", "age": 63, "title": "Strategic Advisor & Director", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 115000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tom  Loughman Ph.D.", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Louise  Barrett", "title": "Senior Vice President of Legal Affairs & Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Steven I. Aronin M.D.", "title": "Senior VP & Head of Clinical Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.77, "open": 1.78, "dayLow": 1.76, "dayHigh": 1.845, "regularMarketPreviousClose": 1.77, "regularMarketOpen": 1.78, "regularMarketDayLow": 1.76, "regularMarketDayHigh": 1.845, "beta": 2.248, "forwardPE": -2.2317073, "volume": 268886, "regularMarketVolume": 268886, "averageVolume": 2975996, "averageVolume10days": 761670, "averageDailyVolume10Day": 761670, "bid": 1.8, "ask": 1.83, "bidSize": 600, "askSize": 400, "marketCap": 50354100, "fiftyTwoWeekLow": 0.808, "fiftyTwoWeekHigh": 3.02, "fiftyDayAverage": 1.7236, "twoHundredDayAverage": 1.408985, "currency": "USD", "enterpriseValue": 40783152, "floatShares": 21960102, "sharesOutstanding": 27515900, "sharesShort": 2531938, "sharesShortPriorMonth": 215246, "sharesShortPreviousMonthDate": 1727654400, "dateShortInterest": 1730332800, "sharesPercentSharesOut": 0.111499995, "heldPercentInsiders": 0.01811, "heldPercentInstitutions": 0.08988, "shortRatio": 0.46, "shortPercentOfFloat": 0.1153, "impliedSharesOutstanding": 27515900, "bookValue": -0.474, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -28337000, "trailingEps": -1.76, "forwardEps": -0.66, "lastSplitFactor": "1:15", "lastSplitDate": 1660780800, "enterpriseToEbitda": -1.092, "52WeekChange": -0.11500001, "SandP52WeekChange": 0.25443196, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "ITRM", "underlyingSymbol": "ITRM", "shortName": "Iterum Therapeutics plc", "longName": "Iterum Therapeutics plc", "firstTradeDateEpochUtc": 1527255000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "2a47ad90-f2ae-3045-b6c4-2f53ded8d73b", "messageBoardId": "finmb_318354064", "gmtOffSetMilliseconds": -18000000, "currentPrice": 1.83, "targetHighPrice": 10.0, "targetLowPrice": 5.0, "targetMeanPrice": 7.5, "targetMedianPrice": 7.5, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 11717000, "totalCashPerShare": 0.516, "ebitda": -37364000, "totalDebt": 21620000, "quickRatio": 0.71, "currentRatio": 0.816, "returnOnAssets": -0.73347, "freeCashflow": -28464500, "operatingCashflow": -41950000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-01-02"}]